Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci190646 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von W David Arnold und 25 weiteren Autor:innen. Beteiligte Einrichtung: NextGen Precision Health and. Hauptthemen laut MEDLINE: Sarcopenia, Neuromuscular Junction, Chloride Channels, NAV1.4 Voltage-Gated Sodium Channel. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIAMS NIH HHS, Ohio University.
Abstract (Originalsprache)
Sarcopenia is the age-related loss of muscle strength and size that leads to mobility limitations and loss of independence in older adults. The underlying cellular mechanisms remain unclear, and treatments are limited. As the critical interface between the nervous system and muscle, the neuromuscular junction (NMJ) is essential for muscle activation and force production. Here, we demonstrate that weak older individuals exhibited NMJ transmission failure that correlated with muscle weakness severity. Preclinical experiments showed similar NMJ transmission failure in aged rodents that was associated with localized loss of muscle fiber excitability at the NMJ. This excitability defect, distinct from potential synaptic cholinergic transmission abnormalities, represents a disease mechanism of sarcopenia. Across species, immunohistochemistry identified a localized reduction in the voltage-gated sodium channel specific for skeletal muscle (NaV1.4) at the postsynaptic NMJ membrane. Acute NaV1.4 inhibition with μ-conotoxin GIIIB in adult rats reproduced findings of NMJ transmission failure observed in aged rodents and humans. Finally, ClC-1 chloride ion channel inhibition enhanced muscle excitability and improved NMJ transmission and muscle function in old rodents. Together, these findings demonstrate that NMJ transmission deficits are a key, reversible driver of sarcopenia and reveal a therapeutic target for addressing muscle weakness in aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NextGen Precision Health and.
- Department of Physical Medicine and Rehabilitation, University of Missouri, Columbia, Missouri, USA.
- NMD Pharma A/S, Aarhus, Denmark.
- Ohio Musculoskeletal and Neurological Institute and.
- Department of Biomedical Sciences, Ohio University Heritage College of Osteopathic Medicine, Athens, Ohio, USA.
- Edinburgh Medical School, Biomedical Sciences, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Förderung
- NIA NIH HHS
- NIAMS NIH HHS
- Ohio University
- University of Missouri
- University of Edinburgh
- Wright State University
Zitieren
APA
Arnold, W. D., Jeppesen Morgen, J., Thomasen, P. B., Broch-Lips, M., Clark, L. A., Groennebaek, T., Skov, M., Winther, J. B., Ramadan, A., Rust, P. A., Myers, J. H., Darvishi, F. B., Dashtmian, A. R., Fish, L. A., Chugh, D., Bold, J., Quiroz, J., Hutchison, J., Nishimune, H., …, & Clark, B. C. (2026). Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition. Journal of Clinical Investigation. https://doi.org/10.1172/jci190646
Vancouver
Arnold WD, Jeppesen Morgen J, Thomasen PB, Broch-Lips M, Clark LA, Groennebaek T, et al. Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition. Journal of Clinical Investigation. 2026. doi:10.1172/jci190646
BibTeX
@article{Arnold2026,
author = {Arnold, W David and Jeppesen Morgen, Jeanette and Thomasen, Pernille Bogetofte and Broch-Lips, Martin and Clark, Leatha A and Groennebaek, Thomas and Skov, Martin and Winther, Jeppe Blichfeldt and Ramadan, Abdullah and Rust, Philippa A and Myers, Jessica H and Darvishi, Fereshteh B and Dashtmian, Anna R and Fish, Lauren A and Chugh, Deepti and Bold, Jane and Quiroz, Jorge and Hutchison, John and Nishimune, Hiroshi and Jones, Ross A and Wang, Xueyong and Fallon, Justin R and Gillingwater, Thomas H and Rich, Mark M and Pedersen, Thomas Holm and Clark, Brian C},
title = {Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci190646}
}
EUVIMED